Retinal neovascularization (RNV) occurs when new blood vessels grow on the surface of the retina. While wound repair in the skin and many other tissues involves neovascularization, in the eye, neovascularization can cause severe vision loss and blindness. Nikhlesh K. Singh, DVM, PhD, assistant professor in the Department of Physiology in the College of Medicine at… Read More
A researcher from the University of Tennessee Health Science Center is among principal investigators on a six-year nationwide diabetes prevention clinical trial that released findings today at the American Diabetes Association’s 79th Scientific Sessions in San Francisco. The Vitamin D and Type 2 diabetes (D2d) study found that vitamin D supplementation does not significantly reduce… Read More
Hao Chen, PhD, associate professor in the Department of Pharmacology, and Robert W. Williams, PhD, professor and chair in the Department of Genetics, Genomics and Informatics at the University of Tennessee Health Science Center (UTHSC), have been awarded over $3.14 million in funding to establish an innovative, diverse research model, which will be used to… Read More
Researchers at the University of Tennessee Health Science Center (UTHSC) were part of the federally-funded Women’s Health Initiative (WHI) multisite clinical trial, which released study findings last week showing that postmenopausal women with no previous history of breast cancer reportedly had a 21 percent lower risk of death from breast cancer if they followed a… Read More
Colleen Jonsson, PhD, professor and Endowed Van Vleet Chair of Excellence in Virology at the University of Tennessee Health Science Center (UTHSC), has been awarded over $21 million in funding to establish a Center of Excellence for Encephalitic Alphavirus Therapeutics program aimed at advancing the discovery and development of potent antiviral drug candidates targeting several… Read More
The University of Tennessee Health Science Center’s (UTHSC) Junling Wang, PhD, professor in the Department of Clinical Pharmacy and Translational Science, has been awarded over $1.4 million from the National Institutes of Health (NIH) to further her research on the equity and economic effects of medication management therapy programs. Her project titled, “Equity and Economic Effects… Read More
Ramesh Narayanan, PhD, associate professor in the Department of Medicine-Hematology and adjunct associate professor in the Departments of Urology and Pharmaceutical Sciences at the University of Tennessee Health Science Center (UTHSC), has been awarded over $2 million from the National Institutes of Health (NIH) to develop novel tools and next generation drugs designed to treat… Read More
Glaucoma is the leading cause of irreversible blindness in the world and affects more than three million people in the United States each year. Currently, there is no cure for this crippling disease, only the option to treat one’s symptoms. Monica M. Jablonski, PhD, professor in the Department of Ophthalmology in the College of Medicine… Read More
